Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer ...

Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW YORK, NY, AND CAMBRIDGE, MA / ACCESS ...

Credit: Getty Images Steven Grinspoon, MD, and Matthew J Feinstein, MD, MSc, discuss ways to reduce CVD risk in patients with HIV. While further research is needed to elucidate the nature of CVD in ...

The latest episode of The Top Line, sponsored by ViiV Healthcare, features Dr. Luis Buzón, an infectious disease specialist, discussing the critical role of real-world evidence in HIV treatment and ...

The components of TAF/FTC and TDF/FTC have activity against hepatitis B virus (HBV). When persons with chronic HBV infection are prescribed TDF/FTC or TAF/FTC, these agents will also have an effect on ...

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

The fight against HIV remains a major public health challenge, primarily due to the persistence of viral reservoirs that require lifelong antiretroviral treatment. However, some individuals, known as ...

Comparative Study of Chemotherapy Tolerance and Immune Function Changes in Gynecological Malignancy Patients with HIV ...

Although early HIV diagnosis is crucial for longevity, women are more likely to be diagnosed late because they are not considered a high-risk group ...